ArticlePharmaceuticals (Basel, Switzerland)2026

Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study.

Alicia Trenas-Calero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.